chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A report has been received from a health professional concerning a 51 year old, female patient, who had been receiving FLUMIST quadrivalent (intranasal), 0.2 milliliters, and once/single administration. FLUMIST quadrivalent started on 16-Oct-2015. The reporter stated that the patient was administered FLUMIST quadrivalent 0.2ml today which started on 16-Oct-2015. FLUMIST quadrivalent was discontinued on 16-Oct-2015. The patient recovered from administered FLUMIST to 51 year old consumer on 16-Oct-2015. The report was considered to be non-serious.
This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose BNT162B2 (COVID-19 VACCINE), via an unspecified route of administration on 23Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient was experiencing back pain after the 1st dose of Covid-19 vaccine given last 23Feb2021. The patient took Tylenol for pain. She would be given 2nd dose on 16Mar2021. Outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Swollen, red and hot at the injection site.  This went away after 3 days but then returned a week later.  I am prone to migraines but I had a very bad one, then I had stomach distress and loose/urgent stool.  I felt nausea and lethargy.  I have a very swollen lympth node on my left side above my collar bone.  I've never had one so swollen before, nor have I had one in that exact spot.  I've had minor swelling of the lympth nodes in my neck when I was very sick before but never like this.  I am beginning to feel better today 5/4/21 and my shot was on 4/23/21.
Administered monovalent booster 8 days after the monovalent vaccine authorization for boosters was revoked. At the time of administration only bivalent vaccines could be administered.
tongue tingling, throat and mouth feels swollen, flushing. Evaluated by EMS-Cleared
Narrative: VACCINE #2 ON 2/19 @ 14:15--HAD TO WAIT IN OBSERVATION FOR 40MINS DUE TO DIZZY, CHILLS AND TONGUE FELT LIKE IT WAS SWELLING AND FUNNY TASTE IN MOUTH. UPPER ARM SWOLLEN, UPPER ARM REMAINED SWOLLEN FOR 35 DAYS AND CONTINUES TO ITCH INTERMITTENTLY TO THIS DAY PER PATIENT REPORT ON 2/26--EXPERIENCED VERTIGO, VOMITING, (DIARRHEA X1 WEEK). WIFE FOUND PATIENT ON THE FLOOR, AMBULANCE CALLED, PATIENT AWAKE THE ENTIRE TIME--TAKEN TO A HOSPITAL.
pt complained of light-headedness, chest tightness, and nausea.  symptoms lasted about20-30 minutes, then pt mostly complained of nausea, gave pt cold washcloth, water and meclizine 12.5mg.  about 10-15 minutes after taking meclizine, said he felt good enough to walk out of store
pt exp diarrhea 24SEp;8hr later upset stomach;7hr later dyspnea;
pt recv vax 27JUL98 & c/o malaise, low grade fever & nasal congestion;6AUG98 devel erythematous macular papular rash on face, trunk & extremities;
7 days after the shot, the arm that received the shot got very itchy, irritated, and a little red. It is currently 8 days after the shot and my arm is still very itchy and feels a little swollen.
Tested positive for COVID; congestion and a cold; congestion and a cold; Cough; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm on 15Apr2021 around 15:50 (at age of 41 years old, Lot Number: EW0158; Expiration Date: Jul2021) as single dose for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient stated she was calling about the Pfizer COVID 19 vaccine that she received on Thursday (15Apr2021), on Thursday and Friday she was fine and then Saturday (17Apr2021) she started experiencing congestion and a cold, cough. The treatment received included Tylenol. Patient stated her kids also got sick and on 19Apr2021 she was tested for COVID and result was positive for COVID. The outcome of event "Congestion nasal" was recovering. The outcome of event "Cough" was not recovered. The outcome of other events was unknown.  No follow-up attempts are needed. No further information is expected.
3-27-09 1:00 PM - began experiencing rt. eye itching, burning, watery raw @ rt. corner of eye, later in day blister appeared corner of rt. eye went to Dr. on 3-28-09 Tx - Zpack & steroid cream. 3-30-09 whelp appeared on rt. cheek, itching nerves tender in cheek area (Rt.) 3-31-09 - whelp red, raised tender to bottom of rt. jaw 4-1-09 Dr. Tx Prednisone Acyclovir
Received a booster shot instead of full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Received a booster shot instead of full dose) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 012M20A and 012M20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced UNDERDOSE (Received a booster shot instead of full dose). On 03-Nov-2021, UNDERDOSE (Received a booster shot instead of full dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment medications were not provided.
dec appetite;inc sleep;inc irritability while awake;all lasted less than 24hr approx 18hr;
Per MOC about 24 hour post vaccinations she noticed child's arm appeared red, swollen, warm and hard. When asked about itchiness, patient admitted to having some this morning. Patient seen in clinic at 2:30 pm. on 7/10/18. Swelling and redness measuring approx. 100 mm by 80 mm. 25 mg of BENADRYL Suspension given. Assessed 35 minutes post administration and redness measuring the same. However, the swelling had resolved. Prednisone 30 mg oral tablet prescribed. Give 1 tablet PO twice a day for 5 days. Spoke to mother of child on 7/17/18. Patient completed course of medication. MOC states on 7/11/18 the site showed no signs as the previous day (7/10) documented above. Patient has been asymptomatic since.
arthralgia/myalgia-cont severe to mod pain;upper resp infect-head & chest decongestant expectorant;photophobia-sl to mod-ended in 4 or 5 wk;
Information has been received from a registered nurse concerning an adult employee who on Nov 20, 2002 was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot #643785/0872M). Subsequently, the patient developed a headache and a temperature of 102F for four days. The Patient also developed an injection site reaction with swelling, induration, edema, and red streaks from the shoulder to the elbow. Unspecified medical attention was sought. The reporter mentioned that other patients also had experience following vaccination with pneumococcal vaccine 23 polyvalent (WAES0211USA02459 and WAES0301USA00466). Additional information has been requested.
Child developed a rash on trunk 3-5 days after receiving vaccinations that spread to legs and arms and face along with a low grade temp. The rash looks like measles in appearance. They have taken him to his personal physician 2 times and to ER once. He has been treated with oral steroids and Benadryl.
Redness present about 2 in x 2in, minor swelling, and patient states soreness from deltoid area to bicep area of left arm. Patient placed cold compresses for 20 minutes at a time.
she felt tingling down her arm into her fingertips like going numb; tightening of her chest, head and sinus cavity; tightening of her chest, head and sinus cavity; stabbing pain in her right eye; felt very very weak; disoriented; tightening of her chest, head and sinus cavity; a little nausea; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (she felt tingling down her arm into her fingertips like going numb), TENSION HEADACHE (tightening of her chest, head and sinus cavity), SINUS HEADACHE (tightening of her chest, head and sinus cavity), EYE DISORDER (stabbing pain in her right eye) and ASTHENIA (felt very very weak) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 075A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PARAESTHESIA (she felt tingling down her arm into her fingertips like going numb), TENSION HEADACHE (tightening of her chest, head and sinus cavity), SINUS HEADACHE (tightening of her chest, head and sinus cavity), EYE DISORDER (stabbing pain in her right eye), ASTHENIA (felt very very weak), DISORIENTATION (disoriented), CHEST DISCOMFORT (tightening of her chest, head and sinus cavity) and NAUSEA (a little nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 17-Mar-2021, PARAESTHESIA (she felt tingling down her arm into her fingertips like going numb), EYE DISORDER (stabbing pain in her right eye), ASTHENIA (felt very very weak), DISORIENTATION (disoriented), CHEST DISCOMFORT (tightening of her chest, head and sinus cavity) and NAUSEA (a little nausea) had resolved. On 18-Mar-2021, TENSION HEADACHE (tightening of her chest, head and sinus cavity) and SINUS HEADACHE (tightening of her chest, head and sinus cavity) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication provided.
Within 30 seconds of injection of COVID vaccine, pt developed red raised macular/lacey rash on trunk, neck, extremities. She developed pallor in her face and lips. Reported pain in arm. Pt said she did not fell well.   Temp 98.1 BP 104/62 P 107 Resp 20 SpO2 98% Lungs clear to auscultation No lip, mouth or throat swelling No vomiting  Benadryl and epinephrine were ready, but symptoms began to spontaneously resolve, so we held off on administering medications.   Within 2 minutes rash was fading and was fully resolved within 5 min. Pt was able to drink water and have lollipop. Felt well by her report.
This spontaneous report as received from a physician refers to a patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL, (lot # J007354, expiry date: 20-FEB-2016). On an unknown date the patient experienced injection site irritation and injection site swelling. The outcome of injection site irritation and swelling is unknown. The relatedness between the GARDASIL and the events was not provided. Additional information has been requested.
11/16/00, right deltoid was swollen. He said he felt feverish and applied ice to right deltoid. On 11/17/00 at 06:30, arm swelling dispersed, approx. 8" X 4", mild redness and swelling and soreness. Ice applied and took Tylenol previous night and morning. Swelling subsided by 11/20/00.
Patient received his second Covid vaccination.  A few minutes later, patient state that "the shot felt different in my arm" and felt dizziness, nausea, and was pale in color.  At 1100, blood pressure was 141/82 P 58.  Offered a snack and water.  Patient sipped on cold water and refused offer of candy, peanut butter crackers, juice, and crackers.  Patient's mother states that he had a Propel drink this morning.  Patient transferred to cot with 2 assist and patient noted to have warm, clammy skin.  Cold cloth applied. Continued to observe patient.  At 1120, patient states that he feels weak and states that he has upper abdominal pain near his ribs.  BP, 121/74 P 53. Offered patient saltines and patient accepted.  Patient took bites of saltine when prompted by nurse.  At 1125, patient states that he feels slightly better and color pink. Mother states that he ate mozzarella sticks and chicken strips for supper last night after work but has not had anything else to eat since.  Mother states that he developed flu like symptoms after getting a flu shot when he was in kindergarten but no other problems with injections or vaccinations. Mother states that he does not take any medications and does not have any health issues.  At 1130, patient states that he feels about the same.  At 1136, patient states that "pain in striking my body" in different areas, including his left arm, stomach and stabbing pains in the left side of his chest. Patient pale.  At 1137, text sent to system. BP 117/74 P 59.  Patient states that he feels weak and left sided chest pain.  ANP responded with cardiology team for assessment. At 1140, BP 121/83 P 57.  Discussed transport to ED for further evaluation.  Patient states that he still feels weak.  Patient and mother okay for ambulance transport to ED.  911 contacted for ambulance transport at 1143.    IV of NS started in Left AC with 20 gauge angiocath on first attempt by cardiology nurse.  Patient left by EMS via stretcher.
BAD STOMACH ACHE; This spontaneous report received from a patient concerned a 57 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and non alcoholic, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A expiry: 21-JUN-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021, the subject experienced bad stomach ache. Laboratory data (dates unspecified) included: Abdominal X-ray (NR: not provided) Not reported. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bad stomach ache. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Tinitis, ringing in both ears started the next day in the morning after the Moderna shot . My ears have been ringing non-stop, it never stops, ringing in the ears 24/7.
The week following my 2nd dose I started experiencing heart palpitations/irregular heartbeat, insomnia and anxiety. Thought it was stress related. Symptoms worsened over the next month following sinus surgery. In additions to previous symptoms, I had shakiness, sweating, muscle weakness, brain fog, hair loss. Thought it was from surgery recovery and meds.
Migraine with aura. Took nurtec ODT and zofran 8mg for it. Slept. Following day dizziness then feeling off and sensitive to light for weeks. Just now starting to feel a tiny bit better.
Arthralgia that started sometime in the middle of the night or early morning on January 16th  and lasted until 6 or 7 pm (January 16th). It was relieved with Ibuprofen and APAP.
About an hour after -heart raced; Felt nauseous; Headache; Dizzy; Almost passed out hot flash; Felt like couldn't breath; Mild rash face/arm/legs/torso; A week later today still icky; Sore throat; almostpassed out; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Apr2021 at 12:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included below right below knee amputation, right arm amputation and stoma. The patient had known many allergies (unspecified) to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASPIRIN), magnesium (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), alprazolam (XANAX) and tapentadol hydrochloride (NUCYNTA); all for unspecified indication, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 15Apr2021 at 13:30, about an hour after vaccination, the patient experienced heart raced, felt nauseous, headache, dizzy, almost passed out, hot flash, felt like could not breathe, mild rash on face, arm, legs, torso. A week later today still patient felt icky but had not major symptoms, but had little dizzy, sore throat and headache. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events heart raced, felt nauseous, headache, dizzy, almost passed out, hot flash, could not breathe, almost passed out, mild rash face, arm, legs, torso, still icky, little dizzy, sore throat, and headache were resolving at the time of report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a Doctor of pharmacy refers to a 79 year old female patient with high blood pressure, cholesterol and unspecified type of cancer and with no drug reactions or allergies. On 24-JUL-2013 at 12:00 pm, the patient was vaccinated with 0.5 ml dose of PNEUMOVAX23 (Lot # H014561, expiration date 21-MAR-2014) IM in the right arm. Concomitant therapies included unspecified medications for high blood pressure and cholesterol. The pharmacist reported that on the evening of 24-JUL-2013, the patient developed a fever of 106 F and redness and swelling from the injection site down past her elbow. The patient called the pharmacist on 24-JUL-2013 and the pharmacist advised her to take BENADRYL, ibuprofen and TYLENOL and to place ice on the redness and swelling. The pharmacist reported that the patient did not report any difficulty breathing. The pharmacist reported that the patient followed her instructions for treatment and also went to a physician's office the morning of 25-JUL-2013. At the physician's office, the patient's temperature was recorded to be 99 F and the physician instructed the patient to stop taking any medications to treat a fever. The pharmacist reported that after the patient left the physician's office she went to see the pharmacist and the pharmacist inspected the patient's arm. The pharmacist reported that there was slight bruising at the injection site, however a red, swollen hardened bubble began about 3 inches below the injection site and extended past her elbow. The patient stated that the bubble did not hurt unless you press on about 3 inches below the injection site and extended past her elbow. The patient stated that the bubble did not hurt unless you press on it. At the time of the report, the patient was recovering. Additional information has been requested.
24 hours after vaccine redness & swelling at site.  Seen at 72 hours after administration.  10 X 8 cm area of erythema with 2 X 2 cm area induration.  Redness & swelling much less today per mom
Fainted driving home and wrecked. Confused and could not see colors. Color blind for several hours.
prominent lower axillary swelling same side as shoulder injection site; Flu-like symptoms; soreness (other than injection areas including thighs); soreness (other than injection areas including thighs); more severe soreness/generalized soreness (other than injection areas including thighs); more severe soreness including back of shoulder; generalized weakness; This is a spontaneous report from a contactable physician (patient himself). A 49-year-old male patient received a second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231; expiry date: unknown) via an unspecified route of administration (right arm), on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received chlorhexidine and propylene glycol and experienced allergies. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date unknown) in the left arm on 17Dec2020 at 17:30 for COVID-19 immunization. On 08Jan2021, the patient experienced more severe soreness including back of shoulder, generalized weakness, and generalized soreness (other than injection areas including thighs) beginning at 13:00 following day lasting the rest of the day. On an unspecified date, the patient also had prominent lower axillary swelling same side as shoulder injection site, flu-like symptoms, and focal soreness. The patient received over the counter (OTC) Motrin as treatment for the events. The patient recovered from flu-like symptoms, but has not yet recovered from the remaining events.
pt contracted COVID -19 post vaccine dose #1.  the vaccine was given on January 12, 2021 and she was diagnosed via laboratory testing on January 22 and informed January 23 of a positive test result.  She was admitted to the hospital on February 1 due to SOB caused by COVID 19 per the clinician's note.  She had a 4 day hospital stay and was discharged on February 4, 2021.
swelling on the injection site/swollen/a whole 5 inches below the injection site/slight swelling; Red; feels slightly warm to the touch compared to the other arm/slightly warm to touch; kind of tender to the touch/Tender; the feeling of wanting to go back into bed and sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling on the injection site/swollen/a whole 5 inches below the injection site/slight swelling), ERYTHEMA (Red), VACCINATION SITE WARMTH (feels slightly warm to the touch compared to the other arm/slightly warm to touch), VACCINATION SITE PAIN (kind of tender to the touch/Tender) and SOMNOLENCE (the feeling of wanting to go back into bed and sleep   ) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A, 013M20A and 035C21A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU on 15-Oct-2021.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling on the injection site/swollen/a whole 5 inches below the injection site/slight swelling), ERYTHEMA (Red), VACCINATION SITE WARMTH (feels slightly warm to the touch compared to the other arm/slightly warm to touch), VACCINATION SITE PAIN (kind of tender to the touch/Tender) and SOMNOLENCE (the feeling of wanting to go back into bed and sleep   ). At the time of the report, VACCINATION SITE SWELLING (swelling on the injection site/swollen/a whole 5 inches below the injection site/slight swelling), ERYTHEMA (Red), VACCINATION SITE WARMTH (feels slightly warm to the touch compared to the other arm/slightly warm to touch), VACCINATION SITE PAIN (kind of tender to the touch/Tender) and SOMNOLENCE (the feeling of wanting to go back into bed and sleep   ) outcome was unknown.            No concomitant and treatment drugs were provided.   This case was linked to MOD-2021-356400.   Most recent FOLLOW-UP information incorporated above includes: On 18-Oct-2021: Significant follow-up : AE added On 18-Oct-2021: Significant Follow Up Appended; Mailbox Contains Pictures to describe the event